ArcBest Corporation (FRA:AQY)
70.00
-3.00 (-4.11%)
Last updated: Jul 30, 2025
Intra-Cellular Therapies Market Cap
ArcBest has a market cap or net worth of €1.38 billion as of August 1, 2025. Its market cap has decreased by -48.03% in one year.
Market Cap
1.38B
Enterprise Value
1.69B
Revenue
3.45B
Ranking
n/a
PE Ratio
10.27
Stock Price
$70.00
Market Cap Chart
Since July 20, 1992, ArcBest's market cap has increased from 101.48M to 1.38B, an increase of 1,264.62%. That is a compound annual growth rate of 8.23%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 31, 2025 | 1.46B | -30.88% |
Dec 31, 2024 | 2.11B | -18.04% |
Dec 29, 2023 | 2.57B | 60.81% |
Dec 30, 2022 | 1.60B | -40.61% |
Dec 31, 2021 | 2.69B | 204.02% |
Dec 31, 2020 | 886.30M | 41.28% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 294.64B |
Siemens Aktiengesellschaft | 176.59B |
Deutsche Telekom AG | 154.90B |
Allianz SE | 131.98B |
Rheinmetall AG | 79.38B |
Siemens Energy AG | 77.36B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 74.55B |
Deutsche Bank Aktiengesellschaft | 54.97B |